Volume 9, Number 11—November 2003
Synopsis
Toxoplasma gondii Infection in the United States, 1999–2000
Jeffrey L. Jones*
, Deanna Kruszon-Moran†, and Marianna Wilson*
, Deanna Kruszon-Moran†, and Marianna Wilson*
Table
Comparison of Toxoplasma gondii immunoglobulin G antibody seroprevalence in NHANES 1999–2000 and NHANES III (1988–1994)a,b,c
| NHANES 1999–2000 | NHANES III | |||||
|---|---|---|---|---|---|---|
| Nd |
Prevalence |
95% CL |
Nd |
Prevalence |
95% CL |
|
| Total |
4,234 |
15.8 |
13.5, 18.1 |
11,132 |
16.0 |
14.5, 17.5 |
| Sex |
||||||
| Male |
2,013 |
16.7 |
13.6, 19.9 |
5,144 |
16.7 |
14.8, 18.6 |
| Female |
2,221 |
14.9 |
12.5, 17.4 |
5,988 |
15.3 |
13.5, 17.0 |
| Race/ethnicity |
||||||
| Non-Hispanic white |
1,293 |
12.1 |
9.9, 14.4 |
3,304 |
14.3 |
12.5, 16.2 |
| Non-Hispanic black |
1,027 |
19.2 |
14.8, 23.6 |
3,674 |
18.0 |
16.1, 19.8 |
| Mexican American |
1,553 |
16.8 |
12.4, 21.1 |
3,661 |
18.3 |
16.7, 20.0 |
| Age group |
||||||
| 12–19 |
2,105 |
9.3 |
6.4, 12.1 |
2,749 |
8.5 |
6.4, 10.5 |
| 20–29 |
735 |
13.4 |
10.1, 16.7 |
3,100 |
15.2 |
12.1, 18.3 |
| 30–39 |
726 |
18.1 |
14.7, 21.5 |
2,960 |
16.1 |
14.6, 17.6 |
| 40–49 |
668 |
20.4 |
15.7, 25.0 |
2,323 |
22.2 |
19.4, 25.0 |
| Country of birth |
||||||
| United States |
3,211 |
12.2 |
10.0, 14.3 |
8,606 |
14.1 |
12.7, 15.5 |
| Non-U.S. | 995 | 32.8 | 27.3, 38.3 | 2,493 | 27.9 | 24.1, 31.7 |
aNHANES, National Health and Examination Survey.
bSex, race/ethnicity, and total values are age-adjusted to the 2000 census estimated population, using the four age categories shown in the table.
cNo statistically significant differences (p>0.05, t-statistic) existed between NHANES 1999–2000 and NHANES III across any subgroup in the table.
dTotals for the race/ethnicity or country of birth categories do not add up to the total number because of an “other” category for race/ethnicity (not shown) or because persons did not provide a response to country of birth questions.
Page created: January 20, 2011
Page updated: January 20, 2011
Page reviewed: January 20, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.